Author

D. Maeda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

J. Zebala· 2 shared A. Athanas· 1 shared A. Khodadadi-Jamayran· 1 shared A. Oleskie· 1 shared A. Richmond· 1 shared B. G. Neel· 1 shared C. Fedele· 1 shared C. Yan· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Zebala

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth

J. Yang, K. Bergdorf, C. Yan, W. Luo, S.-C. Chen, D. Ayers, Q. Liu, X. Liu, M. R. Boothby, S. M. Groves, A. Oleskie, X. Zhang, D. Maeda, J. Zebala, V. Quaranta, A. Richmond

This study shows that CXCR2 expression in melanoma progenitor cells drives tumor growth by altering transcriptional programs and immune responses.

bioRxiv · Feb 22, 2023 · PreprintCancer Biology

Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC

K. H. Tang, S. Li, A. Khodadadi-Jamayran, J. Jen, H. Han, K. Guidry, T. Chen, Y. Hao, C. Fedele, J. Zebala, D. Maeda, J. Christensen, P. Olson, A. Athanas, K.-K. Wong, B. G. Neel

This study shows that combining SHP2 and CXCR1/2 inhibitors enhances anti-tumor T cell responses in NSCLC by reducing immunosuppressive gMDSCs and promoting effector T cells.

bioRxiv · Mar 21, 2021Cancer Biology